Receptors, Antigen, B-Cell
"Receptors, Antigen, B-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
IMMUNOGLOBULINS on the surface of B-LYMPHOCYTES. Their MESSENGER RNA contains an EXON with a membrane spanning sequence, producing immunoglobulins in the form of type I transmembrane proteins as opposed to secreted immunoglobulins (ANTIBODIES) which do not contain the membrane spanning segment.
| Descriptor ID |
D011947
|
| MeSH Number(s) |
D12.776.124.790.651.950 D12.776.377.715.548.950 D12.776.543.750.705.816.821
|
| Concept/Terms |
Receptors, Antigen, B-Cell- Receptors, Antigen, B-Cell
- Membrane Bound Immunoglobulin
- Bound Immunoglobulin, Membrane
- Immunoglobulin, Membrane Bound
- Membrane-Bound Immunoglobulins
- Membrane Bound Immunoglobulins
- B-Cell Antigen Receptors
- B Cell Antigen Receptors
- Immunoglobulins, Surface
- Receptors, Antigen, B Cell
- Antigen Receptors, B-Cell
- Antigen Receptors, B Cell
- Receptors, B-Cell Antigen
- Immunoglobulins, Membrane-Bound
- Immunoglobulins, Membrane Bound
- Surface Immunoglobulins
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Antigen, B-Cell".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Blood Proteins [D12.776.124]
- Serum Globulins [D12.776.124.790]
- Immunoglobulins [D12.776.124.790.651]
- Receptors, Antigen, B-Cell [D12.776.124.790.651.950]
- Globulins [D12.776.377]
- Serum Globulins [D12.776.377.715]
- Immunoglobulins [D12.776.377.715.548]
- Receptors, Antigen, B-Cell [D12.776.377.715.548.950]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, Immunologic [D12.776.543.750.705]
- Receptors, Antigen [D12.776.543.750.705.816]
- Receptors, Antigen, B-Cell [D12.776.543.750.705.816.821]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Antigen, B-Cell".
This graph shows the total number of publications written about "Receptors, Antigen, B-Cell" by people in this website by year, and whether "Receptors, Antigen, B-Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1996 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 3 | 3 |
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 2 | 1 | 3 |
| 2010 | 2 | 0 | 2 |
| 2011 | 1 | 1 | 2 |
| 2012 | 2 | 3 | 5 |
| 2013 | 4 | 3 | 7 |
| 2014 | 3 | 4 | 7 |
| 2015 | 3 | 1 | 4 |
| 2016 | 7 | 3 | 10 |
| 2017 | 4 | 1 | 5 |
| 2018 | 5 | 2 | 7 |
| 2019 | 3 | 1 | 4 |
| 2020 | 1 | 1 | 2 |
| 2021 | 1 | 3 | 4 |
| 2022 | 1 | 3 | 4 |
| 2023 | 1 | 2 | 3 |
| 2024 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Antigen, B-Cell" by people in Profiles.
-
Impact of PIK3CA gain and PTEN loss on mantle cell lymphoma biology and sensitivity to targeted therapies. Blood Adv. 2024 10 22; 8(20):5279-5289.
-
TFEB activation hallmarks antigenic experience of B lymphocytes and directs germinal center fate decisions. Nat Commun. 2024 Aug 14; 15(1):6971.
-
Antigen-independent, autonomous B cell receptor signaling drives activated B cell DLBCL. J Exp Med. 2024 May 06; 221(5).
-
B-Cell Receptor Signaling and Beyond: The Role of Iga (CD79a)/Ig? (CD79b) in Normal and Malignant B Cells. Int J Mol Sci. 2023 Dec 19; 25(1).
-
Chronic Lymphocytic Leukemia: Disease Biology. Acta Haematol. 2024; 147(1):8-21.
-
Ezh2 Knockout in B Cells Impairs Plasmablast Differentiation and Ameliorates Lupus-like Disease in MRL/lpr Mice. Arthritis Rheumatol. 2023 08; 75(8):1395-1406.
-
Gene dosage changes in KCTD13 result in penile and testicular anomalies via diminished androgen receptor function. FASEB J. 2022 11; 36(11):e22567.
-
Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking. Nat Biotechnol. 2022 08; 40(8):1270-1275.
-
B cell receptor isotypes differentially associate with cell signaling, kinetics, and outcome in chronic lymphocytic leukemia. J Clin Invest. 2022 01 18; 132(2).
-
Vecabrutinib inhibits B-cell receptor signal transduction in chronic lymphocytic leukemia cell types with wild-type or mutant Bruton tyrosine kinase. Haematologica. 2022 01 01; 107(1):292-297.